https://scholars.lib.ntu.edu.tw/handle/123456789/99716
標題: | 非主流醫療產業之發展策略─以保健食品產業為例 The Developmental Strategies of the Non-Mainstream Medicine Industries– Using Health Food Industry as an Example |
作者: | 游敬倫 Yeu, King-Len |
關鍵字: | 非主流醫療產業;互補與另類醫療;保健食品;健康食品;Non-mainstream Medicine Industries;Complementary and Alternative Treatment;Health Care Food;Health Food | 公開日期: | 2006 | 摘要: | 中文摘要 近代主流醫療的發展,約有百餘年,醫學教育以科學實證與邏輯推理為基礎,從抗生素的發現到二十一世紀基因體工程及再生醫學的發展,締造了豐碩的成果,使人類壽命延長了一倍,也享受著前所未有的健康狀態。然而疾病的型態改變了,癌症、慢性病、老化、壓力與精神問題,加上人們對更佳健康狀態永無止盡的追求,使得非主流醫療產業,在最近二十年受到了比以往更多的重視,並且蓬勃發展。它們一般被稱為另類及互補性療法,包含了完整另類療法系統、身心醫學系統、操作與身體基礎療法系統、生物基礎療法系統以及能量醫學。更多的資金與科學家投入此一範疇的研究,更多的民眾自付費用採用這些非主流的方式來治療疾病或追求健康,形成相當可觀的經濟規模。 本研究在非主流醫療產業之發展上,首先進行歷史資料分析研究,針對醫療發展史、人類疾病及主要死因之演化、壽命與人口結構之改變及近年來有關非主流醫療及整合醫學發展之國際性文件進行分析比對,釐清非主流醫療產業之歷史角色與發展趨勢,探討美國、澳洲及台灣之非主流醫療產業之特性與發展方向,並選擇屬於生物基礎療法系統中之保健食品產業為例,以美國、日本、中國大陸、及台灣之保健食品產業發展為主軸,分析其市場規模、發展背景與特色、產品與通路、法規面,並探討其產業結構、成敗原因、與發展方向,並對台灣保健食品產業發展策略提出建議,並由此衍申作為非主流醫療產業之發展策略建議。 有關保健食品產業方面,本研究發現(一)全球保健食品產業發展迅速,經濟價值可觀。(二)台灣具保健食品產業發展優勢,應把握發展契機。(三)市場發展策略宜深耕台灣、發展大陸、切入東南亞、佈局整合亞洲。(四)法規發展策略宜加速改革、考慮双軌並行、強化認證管理導向。(五)產品發展策略宜支持實證導向、研發管理、重視顧客價值。(六)整合策略上宜著重產官學水平整合,善用產業分工優勢、落實貿易、研發製造、行銷、策略聯盟與購併並重之發展主軸。 有關非主流醫療產業方面,本研究發現:(一)非主流醫療產業受到比以往更多的重視與投入。(二)互補與另類醫療,可循保健食品產業之軌跡發展。(三)整合醫學將成為未來發展之重要趨勢之一。 關鍵詞:非主流醫療產業、互補與另類醫療、保健食品、健康食品。 The Developmental Strategies of the Non-Mainstream Medicine Industries – Using Health Food Industry as an Example Abstract In the development of modern mainstream medicine of the recent hundred years, the medical education has been built on the basis of science and logic. Since the invention of antibiotic in 1929 till the development of genetic engineering and regenerative medicine in 21st century, as a result, human life has been extended twice as long and they have enjoyed health never had before. However the type of disease has also been changed as well. Problems of cancer, chronic disease, degeneracy, and stress/mental issues, in addition to the endless desire of even better health have stimulated the development of Non-mainstream Medicine Industries in the most recent 20 years. They have been called “Alternative and Complementary Medicine”, and involved “Complete Alternative Medical System”, “Mind-Body Medical System”, “Manipulative and Body Based Therapy System”, “Biological Based Therapy System”, and “Energy Medicine”. More and more funding has been invested and scientists have involved in the research of this new arena. Increasing number of people is willing to be treated by the Non-mainstream Medicine in their own expenses. They have formed enormous economies of scale. For the development of the Non-mainstream Medicine Industries, this research has primarily focused on historic data analysis in the beginning. Author intended to clarify the historic role and developmental trend of the Non-mainstream Medicine Industries by analysis and comparison of “Medication Developmental History’, “Progressive Development of Human Disease and Death Causes”, “Variation of Human Life and Population Structure”, and “International Documentation of the Development of the Non-mainstream Medicine and Integrated Medicine”. This research also intended to explore the developmental trend and the characteristics of the Non-mainstream Medicine Industries in the United States, Australia, and Taiwan. It has selected the Health Care Food Industry, which is under the System of the Biological Basis Treatment, as an example for this research. It would focus on the development of Health Care Food industry in the US, Japan, Mainland China, and Taiwan, to analyze the Market Size, Developmental Background and Uniqueness, Products and Distribution Channels, Legal Aspect; and explore the Industrial Structure, Critical Factors of Success and Failure, and the Directions for Future Development. Finally the author will be making a proposal of Developmental Strategies for Taiwan Health Care Food Industry, and this proposal will be derived as the Developmental Strategies for the Non-mainstream Medicine Industries. As to the Health Care Food Industry, this research has found the following: (1). The global Health Care Food Industry has been rapidly growing and demonstrated enormous economic value. (2). Taiwan should leverage its developmental advantage in the Health Care Food Industry to catch the opportunity. (3). The market developmental strategy should be in the following: Deeply and Pervasively Focus in Taiwan, Initiate Market Development in Mainland China, Penetrate through South-East Asia Market, and Deployment of Integration in Asia. (4). The Regulation Developmental Strategy should be like: Speeding up the Regulation up-grade, consider Parallel Policy, and focus on the Management of License Qualifications. (5). The Product Developmental Strategy should be supporting Fact Oriented Approaches, R&D Management, Emphasize Customers’ Value. (6). Integrated Strategy should be focusing on the following Developmental Guideline: Horizontal Integration of Industry, Government, and Academy; Leveraging the Advantage of Industrial Value Chain; Realize Trading, R&D and Manufacturing, Marketing and Sales, Strategic Alliance, and Merger & Acquisition. As to the Non-mainstream Medicine Industries, Findings of this research are in the following: (1). More attention has been paid to and significant investment has also been put in Non-mainstream Medicine Industries. (2). Complementary and Alternative Treatment could also follow the track of Health Care Food Industry. (3). The Integrated Medicine will play an important role in the future developmental trend. Key Words: Non-mainstream Medicine Industries, Complementary and Alternative Treatment, Health Care Food, Health Food |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/61621 | 其他識別: | zh-TW |
顯示於: | 會計學系 |
檔案 | 描述 | 大小 | 格式 | |
---|---|---|---|---|
ntu-95-P92744002-1.pdf | 23.31 kB | Adobe PDF | 檢視/開啟 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。